RHYTHM PHARMACEUTICALS, INC. Temporary Equity, Accretion of Dividends
RHYTHM PHARMACEUTICALS, INC. (RYTM) reported Temporary Equity, Accretion of Dividends of $2.17 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Shareholders' Equity
us-gaap:TemporaryEquityAccretionOfDividends · last filed 2026-08-04
- RHYTHM PHARMACEUTICALS, INC. temporary equity, accretion of dividends for the quarter ending 2026-06-30 was $1.06M, a 21.05% decline year-over-year.
- RHYTHM PHARMACEUTICALS, INC. temporary equity, accretion of dividends for the quarter ending 2026-03-31 was $1.10M, a 16.49% decline year-over-year.
- RHYTHM PHARMACEUTICALS, INC. temporary equity, accretion of dividends for the quarter ending 2025-12-31 was $1.33M, a 0.52% decline year-over-year.
- RHYTHM PHARMACEUTICALS, INC. temporary equity, accretion of dividends for the quarter ending 2025-09-30 was $1.38M, a 3.46% increase year-over-year.
- RHYTHM PHARMACEUTICALS, INC. temporary equity, accretion of dividends for fiscal 2025 was $5.38M, a 35.47% increase from fiscal 2024.
- RHYTHM PHARMACEUTICALS, INC. temporary equity, accretion of dividends for fiscal 2024 was $3.97M.
- RHYTHM PHARMACEUTICALS, INC. temporary equity, accretion of dividends for fiscal 2023 was $0.00.
| Period end | Temporary Equity, Accretion of Dividends 3 month | Temporary Equity, Accretion of Dividends 6 month | Temporary Equity, Accretion of Dividends 9 month | Temporary Equity, Accretion of Dividends 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $2.17M 10-Q · filed 2026-08-04 | $3.50M derived: sum of 3 quarters · filed 2026-08-04 | $4.88M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $1.10M 10-Q · filed 2026-05-05 | $2.44M derived: sum of 2 quarters · filed 2026-05-05 | $3.81M derived: sum of 3 quarters · filed 2026-05-05 | $5.16M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.71M derived: sum of 2 quarters · filed 2026-02-26 | $4.06M derived: sum of 3 quarters · filed 2026-08-04 | $5.38M 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.72M derived: sum of 2 quarters · filed 2026-08-04 | $4.05M 10-Q · filed 2025-11-04 | $5.38M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $1.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $2.67M 10-Q · filed 2026-08-04 | $4.01M derived: sum of 3 quarters · filed 2026-08-04 | $5.34M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $1.32M 10-Q · filed 2026-05-05 | $2.66M derived: sum of 2 quarters · filed 2026-05-05 | $3.99M derived: sum of 3 quarters · filed 2026-05-05 | $5.29M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.67M derived: sum of 2 quarters · filed 2026-02-26 | $3.97M derived: sum of 3 quarters · filed 2026-02-26 | $3.97M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.33M 10-Q · filed 2024-11-06 | $2.63M derived: sum of 2 quarters · filed 2024-11-06 | $2.63M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $1.30M 10-Q · filed 2024-08-06 | $1.30M 10-Q · filed 2025-08-05 | ||
| 2023-12-31 | $0.00 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |